Skip to main content
Log in

Broad-spectrum antibiotics preferable in infections in cirrhosis

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Notes

  1. diagnosis-related group

Reference

  • Lucidi C, et al. A cost analysis of a broad-spectrum antibiotic therapy in the empirical treatment of health care-associated infections in cirrhotic patients. ClinicoEconomics and Outcomes Research : 29 Jun 2017. Available from: URL: https://doi.org/10.2147/CEOR.S130725

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Broad-spectrum antibiotics preferable in infections in cirrhosis. PharmacoEcon Outcomes News 782, 12 (2017). https://doi.org/10.1007/s40274-017-4143-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-017-4143-0

Navigation